Acutaas Chemicals Limited — Updates, 19-05-2026: General Updates

Acutaas Chemicals' subsidiary ACEPL issued 1,111 shares to A.R.Z Pharma for ~5.83 Cr via a preferential issue. This reduces Acutaas's stake from 100% to 90%, making ACEPL a regular subsidiary. Management control remains with Acutaas.